The latest report by IMARC Group, titled “Radiotherapy Market Report by Type (External Beam Radiation Therapy, Internal Radiation Therapy/Brachytherapy, Systemic Radiation Therapy), Application (Skin and Lip Cancer, Head and Neck Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, and Others), End User (Hospitals, Cancer Research Institutes, Ambulatory and Radiotherapy Centers), and Region 2024-2032“, offers a comprehensive analysis of the industry, which comprises insights on the global radiotherapy market trends. The global market size reached US$ 6.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 9.7 Billion by 2032, exhibiting a growth rate (CAGR) of 3.9% during 2024-2032.

Factors Affecting the Growth of the Radiotherapy Industry:

• Technological Advancements:

Technological advancements in radiotherapy are contributing to market growth. Innovations such as image-guided radiotherapy (IGRT), intensity-modulated radiotherapy (IMRT), and proton therapy transformed cancer treatment by enhancing precision. IGRT allows doctors to view tumors in real-time during treatment, ensuring that radiation is accurately delivered to the cancer cells while sparing healthy tissues. IMRT further refines this approach by varying the intensity of radiation beams, allowing for more exact shaping of the doses according to the tumor's contours. Besides this, proton therapy uses protons to provide a beam that stops at the tumor, reducing radiation exposure to surrounding healthy tissues and minimizing side effects. These technological enhancements improve patient outcomes and reduce the long-term complications associated with traditional radiation therapy.

• Increasing Incidence of Cancer:

The global increase in cancer incidence is a major driver of the demand for radiotherapy. As cancer continues to impact a larger segment of the population, the need for effective treatment modalities becomes more critical. Radiotherapy is a primary or adjunctive treatment option, especially for tumors that are inoperable or challenging to remove surgically. The versatility of radiotherapy in treating various cancers, from breast and prostate to head and neck cancers, underscores its indispensable role in oncology. Besides this, the rising cancer rates can be attributed to the growing geriatric populations, lifestyle choices, and genetic predispositions. It necessitates improved healthcare responses, where radiotherapy plays a crucial role due to its ability to precisely target and destroy cancer cells with minimal impact on the patient's overall health.

• Growing Awareness and Education:

Increasing awareness and education about the benefits of radiotherapy led to the adoption and market expansion. Educational campaigns and initiatives by health organizations and cancer societies help demystify radiotherapy for patients and healthcare providers, leading to greater acceptance and utilization. These efforts are crucial in dispelling myths and misconceptions about radiotherapy, such as fears about the pain and potential side effects associated with treatment. Moreover, as patients become more informed, they are more likely to advocate for advanced treatment options, including radiotherapy. This growing patient-driven demand compels healthcare systems and providers to invest in the latest radiotherapy technologies, further driving market growth.

Competitive Landscape with Key Player:

• Accuray Incorporated
• Becton Dickinson and Company
• Eckert & Ziegler
• Elekta AB (publ)
• General Electric Company
• Hitachi Ltd
• Ion Beam Applications
• Isoray Inc.
• Mevion Medical Systems Inc.
• Nordion Inc. (Sotera Health)
• Siemens Healthineers AG (Siemens AG)

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/radiotherapy-market/requestsample

Report Segmentation:

The report has segmented the market into the following categories:

Breakup by Type:

• External Beam Radiation Therapy
  • Intensity-Modulated Radiation Therapy (IMRT)
  • Image-Guided Radiation Therapy (IGRT)
  • Tomotherapy
  • Stereotactic Radiosurgery
  • Stereotactic Body Radiation Therapy
  • Proton Therapy
  • 3D Conformal Radiotherapy (3D CRT)
  • Volumetric Modulated Arc Therapy (VMAT)
• Internal Radiation Therapy/Brachytherapy
• Systemic Radiation Therapy

External beam radiation therapy holds the largest market segment owing to its widespread use in treating various types of cancers.

Breakup by Application:

• Skin and Lip Cancer
• Head and Neck Cancer
• Breast Cancer
• Prostate Cancer
• Cervical Cancer
• Lung Cancer
• Others

Breast cancer represents the largest market share due to the rising incidence rates and the widespread adoption of radiotherapy as a treatment option.

Breakup by End User:

• Hospitals
• Cancer Research Institutes
• Ambulatory and Radiotherapy Centers

Ambulatory and radiotherapy centers account for the largest market segment owing to the convenience and accessibility they offer to patients seeking radiotherapy treatments.

Market Breakup by Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America’s dominance in the radiotherapy market is attributed to advanced healthcare infrastructure, favorable reimbursement policies, and rising awareness regarding cancer treatment options.

Global Radiotherapy Market Trends:

At present, the widespread adoption of stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) techniques are gaining popularity. It is due to their ability to deliver high doses of radiation with pinpoint accuracy, making them effective options for treating tumors in various parts of the body, including the brain, lungs, liver, and spine. Moreover, the rising focus on personalized medicine is becoming increasingly important in radiotherapy, with advancements in imaging technologies and genetic profiling enabling tailored treatment plans based on individual patient characteristics and tumor biology. Besides this, collaboration between radiotherapy equipment manufacturers, healthcare providers, research institutions, and regulatory bodies is fostering innovation and driving the development of new treatment modalities and technologies.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145 | United Kingdom: +44-753-713-2163